Ausgabe 9/2008
Inhalt (10 Artikel)
Treatment Options for High-Risk T1 Bladder Cancer
Christian Weiss, Oliver J. Ott, Michael Wittlinger, Steffen F. Krause, Rainer Fietkau, Rolf Sauer, Claus Rödel
Neoadjuvant Capecitabine Combined with Standard Radiotherapy in Patients with Locally Advanced Rectal Cancer
Juergen Dunst, Juergen Debus, Volker Rudat, Joern Wulf, Wilfried Budach, Tobias Hoelscher, Thomas Reese, Stephan Mose, Claus Roedel, Helmut Zuehlke, Axel Hinke
Can an FDG-PET/CT Predict Tumor Clearance of the Mesorectal Fascia after Preoperative Chemoradiation of Locally Advanced Rectal Cancer?
Roy F. A. Vliegen, Regina G. Beets-Tan, Bart Vanhauten, Ann Driessen, Michel Oellers, Alfons G. Kessels, Ann Arens, Geerard L. Beets, Jeroen Buijsen, Angela van Baardwijk, Dirk de Ruysscher, Guido Lammering
Total and Single Doses Influence the Effectiveness of Radiotherapy in Palliative Treatment of Plasmacytoma
Thomas Stölting, Hellen Knauerhase, Gunther Klautke, Günther Kundt, Rainer Fietkau
An Easy Irradiation Technique (Partial Half-Beam) to Reduce Renal Dose in Radiotherapy of Cervical Cancer Including Paraaortic Lymph Nodes
Hilke Vorwerk, Daniela Wagner, Hans Christiansen, Clemens Friedrich Hess, Robert Michael Hermann
Radiotherapieinduzierte Nierenarterienstenose nach Behandlung eines Ewing-Sarkoms
Silvio Tacconi, Sabine Bieri
Complete Remission of a Lymphoma-Associated Chylothorax by Radiotherapy of the Celiac Trunk and Thoracic Duct
Johanna Gerstein, Dorothea Kofahl-Krause, Jörg Frühauf, Michael Bremer
Two New Prognostic Indices for Brain Metastases – Where Do We Go from Here?
Carsten Nieder
Immunohistochemical Detection of HIF-1α and CAIX in Advanced Head-and-Neck Cancer
Matthias Kappler, Helge Taubert, Hans-Jürgen Holzhausen, Rolf Reddemann, Swetlana Rot, Axel Becker, Thomas Kuhnt, Kathrin Dellas, Jürgen Dunst, Dirk Vordermark, Gabriele Hänsgen, Matthias Bache